BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verespy S 3rd, Mehta AY, Afosah D, Al-Horani RA, Desai UR. Allosteric Partial Inhibition of Monomeric Proteases. Sulfated Coumarins Induce Regulation, not just Inhibition, of Thrombin. Sci Rep 2016;6:24043. [PMID: 27053426 DOI: 10.1038/srep24043] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Sun ZG, Yang-Liu, Zhang JM, Cui SC, Zhang ZG, Zhu HL. The Research Progress of Direct Thrombin Inhibitors. Mini Rev Med Chem 2020;20:1574-85. [PMID: 31644402 DOI: 10.2174/1389557519666191015201125] [Reference Citation Analysis]
2 Ferreira RS, Lira AL, Torquato RJS, Schuck P, Sousa AA. Mechanistic Insights into Ultrasmall Gold Nanoparticle–Protein Interactions through Measurement of Binding Kinetics. J Phys Chem C 2019;123:28450-9. [DOI: 10.1021/acs.jpcc.9b08308] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
3 Al-Horani RA, Karuturi R, Lee M, Afosah DK, Desai UR. Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile. PLoS One 2016;11:e0160189. [PMID: 27467511 DOI: 10.1371/journal.pone.0160189] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
4 Lira AL, Ferreira RS, Torquato RJS, Oliva MLV, Schuck P, Sousa AA. Allosteric inhibition of α-thrombin enzymatic activity with ultrasmall gold nanoparticles. Nanoscale Adv 2019;1:378-88. [PMID: 30931428 DOI: 10.1039/c8na00081f] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
5 He X, Ni D, Lu S, Zhang J. Characteristics of Allosteric Proteins, Sites, and Modulators. In: Zhang J, Nussinov R, editors. Protein Allostery in Drug Discovery. Singapore: Springer; 2019. pp. 107-39. [DOI: 10.1007/978-981-13-8719-7_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Morla S, Desai UR. Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8. Biomolecules 2020;10:E1166. [PMID: 32784891 DOI: 10.3390/biom10081166] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hartmann A, Ganzera M, Karsten U, Skhirtladze A, Stuppner H. Phytochemical and Analytical Characterization of Novel Sulfated Coumarins in the Marine Green Macroalga Dasycladus vermicularis (Scopoli) Krasser. Molecules 2018;23:E2735. [PMID: 30360516 DOI: 10.3390/molecules23112735] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Konteatis Z, Artin E, Nicolay B, Straley K, Padyana AK, Jin L, Chen Y, Narayaraswamy R, Tong S, Wang F, Zhou D, Cui D, Cai Z, Luo Z, Fang C, Tang H, Lv X, Nagaraja R, Yang H, Su SM, Sui Z, Dang L, Yen K, Popovici-Muller J, Codega P, Campos C, Mellinghoff IK, Biller SA. Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma. ACS Med Chem Lett 2020;11:101-7. [PMID: 32071674 DOI: 10.1021/acsmedchemlett.9b00509] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 22.5] [Reference Citation Analysis]
9 Sousa AA, Schuck P, Hassan SA. Biomolecular interactions of ultrasmall metallic nanoparticles and nanoclusters. Nanoscale Adv 2021;3:2995-3027. [PMID: 34124577 DOI: 10.1039/d1na00086a] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Lira AL, Ferreira RS, Oliva MLV, Sousa AA. Regulation of Thrombin Activity with Ultrasmall Nanoparticles: Effects of Surface Chemistry. Langmuir 2020;36:7991-8001. [PMID: 32590899 DOI: 10.1021/acs.langmuir.0c01352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Afosah DK, Al-horani RA, Sankaranarayanan NV, Desai UR. Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics. J Med Chem 2017;60:641-57. [DOI: 10.1021/acs.jmedchem.6b01474] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
12 Afosah DK, Al-Horani RA. Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies. Curr Med Chem 2020;27:3412-47. [PMID: 30457046 DOI: 10.2174/0929867325666181120101147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Afosah DK, Verespy S 3rd, Al-Horani RA, Boothello RS, Karuturi R, Desai UR. A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin. Bioorg Med Chem Lett 2018;28:1101-5. [PMID: 29459207 DOI: 10.1016/j.bmcl.2018.01.069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Chen WQ, Yin MM, Song PJ, He XH, Liu Y, Jiang FL. Thermodynamics, Kinetics and Mechanisms of Noncompetitive Allosteric Inhibition of Chymotrypsin by Dihydrolipoic Acid-Coated Gold Nanoclusters. Langmuir 2020;36:6447-57. [PMID: 32460493 DOI: 10.1021/acs.langmuir.0c00699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
15 Morla S, Sankaranarayanan NV, Afosah DK, Kumar M, Kummarapurugu AB, Voynow JA, Desai UR. On the Process of Discovering Leads That Target the Heparin-Binding Site of Neutrophil Elastase in the Sputum of Cystic Fibrosis Patients. J Med Chem 2019;62:5501-11. [PMID: 31074986 DOI: 10.1021/acs.jmedchem.9b00379] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
16 Sowole MA, Simpson S, Skovpen YV, Palmer DR, Konermann L. Evidence of Allosteric Enzyme Regulation via Changes in Conformational Dynamics: A Hydrogen/Deuterium Exchange Investigation of Dihydrodipicolinate Synthase. Biochemistry 2016;55:5413-22. [PMID: 27604304 DOI: 10.1021/acs.biochem.6b00764] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
17 Kar S, Mottamal M, Al-Horani RA. Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia. ChemistryOpen 2020;9:1161-72. [PMID: 33204588 DOI: 10.1002/open.202000277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Potapov AY, Paponov BV, Podoplelova NA, Panteleev MA, Polikarchuk VA, Ledenyova IV, Stolpovskaya NV, Kryl’skii DV, Shikhaliev KS. Synthesis and study of new 2H-pyranoquinolin-2-one-based inhibitors of blood coagulation factors Xa and XIa. Russ Chem Bull 2021;70:492-7. [DOI: 10.1007/s11172-021-3114-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Boothello RS, Sankaranarayanan NV, Afosah DK, Karuturi R, Al-Horani RA, Desai UR. Studies on fragment-based design of allosteric inhibitors of human factor XIa. Bioorg Med Chem 2020;28:115762. [PMID: 32992249 DOI: 10.1016/j.bmc.2020.115762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Acquasaliente L, Peterle D, Tescari S, Pozzi N, Pengo V, De Filippis V. Molecular mapping of α-thrombin (αT)/β2-glycoprotein I (β2GpI) interaction reveals how β2GpI affects αT functions. Biochem J 2016;473:4629-50. [PMID: 27760842 DOI: 10.1042/BCJ20160603] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
21 Demeyer A, Driege Y, Skordos I, Coudenys J, Lemeire K, Elewaut D, Staal J, Beyaert R. Long-Term MALT1 Inhibition in Adult Mice Without Severe Systemic Autoimmunity. iScience 2020;23:101557. [PMID: 33083726 DOI: 10.1016/j.isci.2020.101557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Srinivasan B. Explicit Treatment of Non-Michaelis-Menten and Atypical Kinetics in Early Drug Discovery*. ChemMedChem 2021;16:899-918. [PMID: 33231926 DOI: 10.1002/cmdc.202000791] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Al-Horani RA, Abdelfadiel EI, Afosah DK, Morla S, Sistla JC, Mohammed B, Martin EJ, Sakagami M, Brophy DF, Desai UR. A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding. J Thromb Haemost 2019;17:2110-22. [PMID: 31397071 DOI: 10.1111/jth.14606] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
24 Al-Horani RA, Afosah DK. Recent advances in the discovery and development of factor XI/XIa inhibitors. Med Res Rev 2018;38:1974-2023. [PMID: 29727017 DOI: 10.1002/med.21503] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]